References
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, for the Movement Disorder Society-endorsed PSP Study Group (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864
Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS (2012) Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J Nucl Med 53:399–406
Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C, Kluger B, Olfati N, Jankovic J (2019) Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord 69:34–39
Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A (2019) Dyskinesia in multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna) 126:925–932
Funding
This work was supported by the Soonchunhyang University Research Fund (Grant No. 20200432).
Author information
Authors and Affiliations
Contributions
Conceptualization: Kwon KY; Data curation: Ju H, Lee EJ, Lee M, Kwon KY; Formal analysis: Ju H, Lee EJ, Lee M, Kwon KY; Funding acquisition: Kwon KY; Investigation: Ju H, Lee EJ, Lee M, Kwon KY; Writing - original draft: Ju H, Kwon KY; Writing - review & editing: Ju H, Lee EJ, Lee M, Kwon KY
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
This article does not contain any studies with human participants besides routine clinical diagnostics by any of the authors.
Informed consent
Written informed consent was obtained from the patient.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Video 1
Initial neurological manifestations of the patient. The patient showed a mild degree of akinetic rigid parkinsonism, which was slightly severe in the right limbs compared with the left limbs. The limitation of the extraocular muscles was not observed, while slowness of her saccadic eye movements including the “Round the Houses” sign was suspiciously noted. Her gait and postural stability were unremarkable (MP4 59579 kb)
Video 2
Clinical presentations of the patient one year after. The patient revealed sustained responsiveness of akinetic rigid parkinsonism of all the limbs with a mild degree of dyskinetic movements. Downward supranuclear gaze palsy and apraxia of eyelid opening were noted. In addition, the patient had postural instability and unsteadiness of tandem gait (MP4 73175 kb)
Rights and permissions
About this article
Cite this article
Ju, H., Lee, E.J., Lee, M. et al. Early suspicion of progressive supranuclear palsy using dopamine transporter imaging: an illustrative case presenting with levodopa-responsive parkinsonism. Neurol Sci 42, 3435–3437 (2021). https://doi.org/10.1007/s10072-021-05246-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05246-7